X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (519) 519
Patent (36) 36
Publication (29) 29
Book Chapter (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (225) 225
male (177) 177
female (168) 168
middle aged (146) 146
adult (145) 145
index medicus (128) 128
hematology (125) 125
aged (99) 99
prognosis (88) 88
treatment outcome (76) 76
oncology (74) 74
adolescent (64) 64
chemotherapy (59) 59
antineoplastic combined chemotherapy protocols - therapeutic use (58) 58
young adult (56) 56
survival (48) 48
retrospective studies (36) 36
medicine, general & internal (32) 32
aged, 80 and over (31) 31
chemistry (29) 29
metallurgy (29) 29
risk factors (29) 29
survival analysis (29) 29
acute lymphoblastic leukemia (26) 26
hiv infections - drug therapy (26) 26
stem cell transplantation (26) 26
stem-cell transplantation (26) 26
disease-free survival (25) 25
lymphoma (25) 25
transplantation (25) 25
cancer (24) 24
internal medicine (24) 24
leukemia (24) 24
therapy (24) 24
active antiretroviral therapy (22) 22
aids (22) 22
analysis (22) 22
rituximab (22) 22
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
antiretroviral therapy, highly active (21) 21
lymphomas (21) 21
antineoplastic agents - therapeutic use (20) 20
follow-up studies (20) 20
infectious diseases (20) 20
stem cells (20) 20
b-cell lymphoma (19) 19
care and treatment (19) 19
hematopoietic stem cell transplantation (19) 19
immunology (19) 19
lymphoma, aids-related - drug therapy (19) 19
general tagging of cross-sectional technologies spanning over several sections of the ipc (18) 18
general tagging of new technological developments (18) 18
non-hodgkins-lymphoma (18) 18
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (18) 18
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (18) 18
technologies or applications for mitigation or adaptation againstclimate change (18) 18
time factors (18) 18
trial (18) 18
children (17) 17
combined modality therapy (17) 17
minimal residual disease (17) 17
cytarabine - administration & dosage (16) 16
disease (16) 16
hiv (16) 16
relapse (16) 16
remission induction (16) 16
abridged index medicus (15) 15
acute lymphocytic-leukemia (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
cyclophosphamide - administration & dosage (15) 15
doxorubicin - administration & dosage (15) 15
hematology, oncology and palliative medicine (15) 15
multivariate analysis (15) 15
spain (15) 15
adults (14) 14
cyclophosphamide (14) 14
hiv infections - complications (14) 14
prednisone - administration & dosage (14) 14
recurrence (14) 14
research (14) 14
vincristine - administration & dosage (14) 14
classification (13) 13
intensive chemotherapy (13) 13
lymphoma, large b-cell, diffuse - drug therapy (13) 13
performing operations (13) 13
precursor cell lymphoblastic leukemia-lymphoma - mortality (13) 13
precursor cell lymphoblastic leukemia-lymphoma - therapy (13) 13
survival rate (13) 13
transporting (13) 13
àrees temàtiques de la upc (13) 13
child (12) 12
chromosome aberrations (12) 12
climate change mitigation technologies in the production orprocessing of goods (12) 12
clinical trials (12) 12
health aspects (12) 12
impact (12) 12
non-hodgkin's lymphoma (12) 12
philadelphia chromosome (12) 12
prospective studies (12) 12
remission (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2017, Volume 17, pp. S69 - S71
Journal Article
Medicina Clinica, ISSN 0025-7753, 02/2019, Volume 152, Issue 3, pp. 119 - 120
Journal Article
Medicina Clinica, ISSN 0025-7753, 12/2018, Volume 151, Issue 12, pp. 506 - 507
Journal Article
Medicina Clinica, ISSN 0025-7753, 11/2018, Volume 151, Issue 9, pp. 376 - 377
Journal Article
Expert review of hematology, 12/2017, Volume 10, Issue 12, p. 1057
Immunotherapy is a promising modality of treatment of neoplastic diseases, including acute lymphoblastic leukemia (ALL). The CD19/CD3-bispecific T... 
Journal Article
Haematologica, ISSN 0390-6078, 09/2018, Volume 103, Issue 10, pp. 1581 - 1583
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 12/2017, Volume 10, Issue 12, pp. 1057 - 1067
Introduction: Immunotherapy is a promising modality of treatment of neoplastic diseases, including acute lymphoblastic leukemia (ALL). The CD19/CD3-bispecific... 
relapsed/refractory | blinatumomab | minimal residual disease-positive | Acute lymphoblastic leukemia | BiTE® monoclonal antibodies | refractory | ADULT PATIENTS | PRECURSOR | OLDER-ADULTS | BiTE (R) monoclonal antibodies | ANTIBODY BLINATUMOMAB | PHASE-II | RELAPSE-FREE SURVIVAL | SINGLE-ARM | relapsed | TERM-FOLLOW-UP | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | STANDARD THERAPY
Journal Article
Caplletra, ISSN 0214-8188, 2018, Volume 64, pp. 105 - 107
Journal Article
Medicina Clinica, ISSN 0025-7753, 07/2012, Volume 139, Issue 4, pp. 161 - 162
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 9, pp. 836 - 847
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 11/2011, Volume 23, Issue 6, pp. 692 - 699
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5568 - 5568
INTRODUCTION The combination of intravenous bortezomib, thalidomide and dexamethasone (VTD) is a well described induction treatment for young patients with... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Journal Article
Medicina Clinica, ISSN 0025-7753, 12/2012, Volume 139, Issue 14, pp. 631 - 633
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.